Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Teva- Pharmaceutical Industries Ltd. ADR’s stock clocked out at $16.29, down -1.15% from its previous closing price of $16.48. In other words, the price has decreased by -$1.15 from its previous closing price. On the day, 9.36 million shares were traded. TEVA stock price reached its highest trading level at $16.565 during the session, while it also had its lowest trading level at $16.06.
Ratios:
To gain a deeper understanding of TEVA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.15. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.03.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’25 when Daniell Richard sold 70,961 shares for $15.91 per share. The transaction valued at 1,128,642 led to the insider holds 48,384 shares of the business.
Hughes Eric A sold 15,174 shares of TEVA for $238,757 on Mar 04 ’25. The See “Remarks” now owns 8,077 shares after completing the transaction at $15.73 per share. On Mar 05 ’25, another insider, Hughes Eric A, who serves as the See “Remarks” of the company, sold 8,077 shares for $15.91 each. As a result, the insider received 128,531 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 18672576512 and an Enterprise Value of 33701232640. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13 while its Price-to-Book (P/B) ratio in mrq is 3.44. Its current Enterprise Value per Revenue stands at 2.037 whereas that against EBITDA is 7.606.
Stock Price History:
The Beta on a monthly basis for TEVA is 0.68, which has changed by 0.18472731 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $12.51. The 50-Day Moving Average of the stock is -9.84%, while the 200-Day Moving Average is calculated to be -8.66%.
Shares Statistics:
It appears that TEVA traded 12.33M shares on average per day over the past three months and 12828300 shares per day over the past ten days. A total of 1.15B shares are outstanding, with a floating share count of 1.15B. Insiders hold about 0.02% of the company’s shares, while institutions hold 58.66% stake in the company. Shares short for TEVA as of 1740700800 were 27808217 with a Short Ratio of 2.26, compared to 1738281600 on 22360234. Therefore, it implies a Short% of Shares Outstanding of 27808217 and a Short% of Float of 2.4400001000000002.
